entity

neuronal_survival

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about neuronal_survival: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
1Hypotheses
4Analyses
0Outgoing
4Incoming
1Experiments
4Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (4)

SourceRelationTypeStr
NEUROTROPHINSactivatesprotein0.72
BCL2regulatesentity0.70
IGF1Rregulatesprotein0.64
neurotrophin_signalingpromotespathway0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Heterogeneous astrocyte activation states differentially imp 0.640 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V

Mentioning Analyses (4)

Scientific analyses that reference this entity

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

neurodegeneration | 2026-04-04 | 0 hypotheses

Which metabolic biomarkers can distinguish therapeutic response from disease pro

translational neuroscience | 2026-04-04 | 7 hypotheses Top: 0.819

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.803

Metabolic reprogramming in neurodegenerative disease

neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.652

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
iPSC-NPC effects on astrocytes in vitro ICH model exploratory intracerebral hemorrhage 0.900 0.00 in vitro ICH cell culture mode proposed N/A

Related Papers (12)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Brain atrophy patterns in anti-IgLON5 disease. [PMID:40650880] Yogeshwar SM, Bartels F, Grüter T, Muñiz Brain 2026 0
Potential diagnostic markers in Alzheimer's disease: current perspectives and fu [PMID:40911035] Zheng M, Wang S, Jia J Neurodegener Dis Manag 2026 0
Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Commun [PMID:41337685] Gasparini F, Valletta M, Vetrano DL, Ber Neurology 2026 0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736] Abedin MJ, Kastanenka KV J Alzheimers Dis 2026 0
Biomarker-integrated prognostic stagings for Alzheimer's Disease. [PMID:41622252] Shin D, Lee S, Kim JP, Jang H, Yun J et Nat Commun 2026 0
Prognostic Value of Plasma NfL and GFAP for Conversion to Alzheimer's Disease an [PMID:41703957] Özkurt Ç, Kelicen-Uğur P Biomarkers 2026 0
From scaffold to effector: reframing GFAP in neurodegeneration. [PMID:41775321] Lu YH, Zhu XP, Li S, Zhang FN, Cai CB et J Adv Res 2026 0
Translating neurofilament light chain testing into clinical practice: a multidis [PMID:41831326] Furlan R, Di Sapio A, Ferraro D, Rossi E Clin Chem Lab Med 2026 0
Role of astrocyte biomarker GFAP in early diagnosis and prognosis assessment of [PMID:41850459] Li S, Wei S, Wang L, Yu T, Wang H et al. Int J Biol Macromol 2026 0
Impaired glymphatic function is associated with synaptic loss in cognitive impai [PMID:41454064] He K, Wang J, Wu J, Chen X, Chen H, Li J European journal of nuclear me 2026 0
Cerebral FURIN deficiency impairs astrocytic lipophagy through ITGAV maturation. [PMID:41376284] Xie XY, Wang L, Xie SQ, Zhou GF, Wen QX, Autophagy 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] Aranda-Abreu GE, Rojas-Durán F, Hernánde Neurology international 2026 0

Debates (4)

Multi-agent debates referencing this entity

How do alterations in brain lipid metabolism—including gangliosides, phospholipi

closed · Rounds: 4 · Score: 0.84 · 2026-04-11

Which metabolic biomarkers can distinguish therapeutic response from disease pro

closed · Rounds: 4 · Score: 0.92 · 2026-04-04

Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

How does metabolic reprogramming (glucose metabolism shifts, brain insulin resis

closed · Rounds: 4 · Score: 0.73 · 2026-04-02

Related Research

Hypotheses and analyses mentioning neuronal_survival in their description or question text

No additional research found